THE EFFICACY AND SAFETY OF DIRECT ORAL ANTI-COAGULANTS IN THE PREVENTION OF CEREBROVASCULAR ACCIDENT AND VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WHO WEIGH > 120 KG OR BMI > 40 WHEN COMPARED TO WARFARIN IN THE SETTING OF AN URBAN SAFETY-NET HOSPITAL